All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
Citations
Altmetric
Author
Iland, Harry; Bradstock, Ken; Supple, Shane; Catalano, Alberto; COLLINS, MARNIE; Hertzberg, Mark; Browett, Peter; GRIGG, ANDREW; FIRKIN, FRANK; Hugman, Amanda; ...Date
2012Source Title
BloodUniversity of Melbourne Author/s
Grigg, Andrew; Firkin, Frank; Filshie, Robin; Szer, Jeffrey; Seymour, JohnAffiliation
The Sir Peter Maccallum Department Of OncologyMetadata
Show full item recordDocument Type
Journal ArticleCitations
Iland, H., Bradstock, K., Supple, S., Catalano, A., Collins, M., Hertzberg, M., et al. (2012). All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood, 120(8).Access Status
This item is currently not available from this repositoryDescription
C1 - Journal Articles Refereed
Keywords
Chemotherapy; Cancer and Related DisordersExport Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References